Table 3 Correlations between the concentrations of microparticles binding the various complement components or complement activator molecules in synovial fluid and plasma of RA patients and plasma of healthy individuals.
RA synovial fluid | RA plasma | Control plasma | ||||
---|---|---|---|---|---|---|
r | p Value | r | p Value | r | p Value | |
C1q pos MP vs C4 pos MP | 0.660 | 0.0533 | 0.908 | 0.0007 | 0.632 | 0.0498 |
C1q pos MP vs C3 pos MP | 0.961 | 0.0001 | 0.205 | 0.5963 | 0.542 | 0.1057 |
CRP pos MP vs C1q pos MP | 0.433 | 0.2841 | 0.903 | 0.0021 | 0.683 | 0.0296 |
SAP pos MP vs C1q pos MP | −0.015 | 0.9725 | 0.492 | 0.1786 | 0.280 | 0.4339 |
IgM pos MP vs C1q pos MP | 0.728 | 0.0408 | −0.175 | 0.6527 | 0.159 | 0.6611 |
IgG pos MP vs C1q pos MP | 0.952 | 0.0003 | 0.420 | 0.2606 | 0.505 | 0.1364 |
Correlation analysis was performed using Pearson's correlation test (r, correlation coefficient; p, two‐tailed significance level, considered significant at p<0.05).